CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

EarningsnegativeKresladiNegative
AI Analysis

Summary

Rocket Pharmaceuticals reported a Q1 earnings miss, causing stock decline. The company's Kresladi launch remains a key focus going forward.

Outcome Details

Q1 earnings miss

Importance:5/10
Sentiment:
-0.60
earningsQ1missKresladistock_decline
Related Companies

Read the original article

Published by yahoo_finance on May 11, 2026 3:50 PM

Read Original